Special Issue on Basic Pharmacokinetics in Medicine

Submission Deadline: May 30, 2020

This special issue currently is open for paper submission and guest editor application.

Please download to know all details of the Special Issue

Special Issue Flyer (PDF)

  • Special Issue Editor
    • Department of Biophysics and Basic Pharmacology, Universidad Autónoma de Baja California, Tijuana Baja California, Mexico
    Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to fulfill the Guest Editor application.
    • Alejandro Juan Alvarez
      Department of Molecular Chemestry and Delivery Systems, Instituto Tecnologico de Estudiso Superiores de Monterrey, Monterrey N.L., Mexico
    • Marco Antonio Ramos
      Department of Biochemestry and Biotechnology, Universidad Autonoma de Baja California, Tijuana B.C., Mexico
    • Jorge Arturo Alvelais
      Department of Immulogy, Universidad Autonoma de Baja California, Tijuana B.C., Mexico
    • Jose Manuel Cornejo
      Department of Nanomaterials and Delivery Systems, Universidad Autonoma de Baja California, Tijuana B.C., Mexico
    • Horacio Eusebio Almanza
      Department of Cellular Immulogy and Infectious Disease, Tijuana B.C., Mexico
  • Introduction

    Clinical pharmacokinetics was born as a necessity to obtain a better understanding and correlation between the administration of an active ingredient that is administered to a patient and the therapeutic effect obtained in him or her. This discipline, a subspecialty of medicine, aims to learn how a pharmacologic agent behaves in the body in order to thus establish therapeutic schemes, dose, interval and routes of administration, and also to describe drug interactions, antagonistic and synergistic behaviors, adverse reactions and side effects.
    Bee able to prescribe active ingredients in safe, effective and optimal way in patients in pathological States must be the goal of every physician. This prescription should be an analytical decision taking into account age, sex, concomitant diseases, as well as the implementation of Pharmacokinetic principles in the treatment of the patient.
    Currently we should focus and deepen in the pharmacokinetics of the active principles such as bioavailability, bioequivalence, absorption rate, excretion rate, route of elimination, as well as integrate such as t1/2 which is pharmacokinetic parameters, Vd for the calculation of a pharmacological dose.
    These should be the parameters that need to be analyzed for the creation of therapeutic schemes and individual therapeutic schemes, which I call them TSI, in pharmacologic principles with a narrow therapeutic window (Range). An average dose of an active ingredient does not always provide adequate levels because the concentration in serum depends on factors such as volume of distribution and elimination of the drug speed.These should be the parameters that need to be analyzed for the creation of therapeutic schemes and individual therapeutic schemes, which I call them TSI, in pharmacologic principles with a narrow therapeutic window (Range). An average dose of an active ingredient does not always provide adequate levels because the concentration in serum depends on factors such as volume of distribution and elimination of the drug speed.
    Reason why plasma monitoring allows us to make the appropriate adjustments of dosage and avoid the empirical use of pharmacologic agents, thus bringing as a result of using this parameters the decrease of adverse and side effects in patients. Training in the area of medicine and chemistry has allow us to unite these two Sciences and understand the physiopathologic and chemical and biological aspect in human beings, which is the basis on what clinical pharmacokinetics was founded.
    Aims and Scope:
    1. Therapeutic effect
    2. Clinical pharmacokinetics
    3. Pharmacokinetic parameter's
    4. Analytical prescription
    5. Therapeutic window
    6. TSI

  • Guidelines for Submission

    Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.

    Papers should be formatted according to the guidelines for authors (see: http://www.ijphmchem.org/submission). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.

  • Published Papers

    The special issue currently is open for paper submission. Potential authors are humbly requested to submit an electronic copy of their complete manuscript by clicking here.

Browse journals by subject